Abstract
Henoch-Shoenlein Purpura (HSP) is a multisystem disorder of unknown etiology affecting predominantly the skin, joints, gastrointestinal tract, and the kidneys but other organs can be affected as well. It is one of the most common causes of vasculitic disorders in children. No specific autoantibodies have been detected in HSP, but the presence of IgA depositions in both skin and kidney biopsies and the presence of IgA-containing circulating immune complexes support the immunological pathogenesis. The natural history of the disease is cure in most cases, although recurrence and end-stage kidney disease are described. The treatment consists of corticosteroids and immunosuppressive drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cassidy JT, Petty RE. Vasculitis. In: Text book of Pediatric Rheumatology, 3rd ed. Philadelphia, Wb Saunders Company 1995; pp. 365–422.
Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schoenlein-Henoch syndrome): review with follow-up of renal complications. Am J Dis Child 1960; 99: 833–54.
Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Shoenleine purpura in an unselected childhood population. Eur J Pediatr 1988; 147: 113–15.
Neilsen HE. Epidemiology of Henoch-Schoenlein purpura. Acta Paediatr Scand 1988; 77: 125–31.
Robson WLM, Leung AKC. Henoch-Schoenlein purpura. Adv Pediatr 1994; 41: 163–94.
Lau KK, Wyatt RJ, Moldovenau Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 2007; 22(12): 2067–72.
Novak J, Moldoveanau Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IaA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 2007; 157: 134–8.
Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 2005; 7(4): 270–5.
Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomi MR, Roccatello D, De Marchi M, Carbonara AO, Barbiano di Belgiojoso G. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schonlein nephritis. Clin Exp Immunol 1984, Sep; 57(3): 583–90.
Li YT, Lv JC, Li GT, Jiang L, Song YH, Zhang H. Comparative analysis of clinicopathological findings and outcome of Henoch-Schonlein nephritis and IgA nephropathy in adults. Beijing Da Xue Xue Bao 2007; 39(5): 458–61.
Zhou JH, Huang AX, Liu TL, Kuang YJ. A clinico-pathological study comparing Henoch-Schonlein purpura nephritis with IgA nephropathy in children. Zhonghua Er Ke Za Zhi 2003, Nov; 41(11): 808–12.
Hara M, Yanagihara T, Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Biochemical features: Clin J Am Soc Nephrol 2007; 2(2): 231–8.
Carlson JA, Chen KR. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 2006; 28(6): 486–506.
Kawakami T. Vasculitis from the dermatological point of view. Nihon Rinsho Meneki Gakkai Kaishi 2007; 30(3): 156–64.
Mills JA, Michel BA, Bloch DA, Calabrse LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990; 33: 1114–21.
Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur A, Ravelli A, Woo P. EULAR/PReS endorsed consensus criteria∗ for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936–41.
Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 2002; 360(9334): 666–70.
Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Schonlein purpura nephritis with nephritic-range poteinuria: histological regression possibly associated with cyclosporine A and steroid treatment. Scand J Rheumatol 2005; 34(5): 392–5.
Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ. Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 2005; 20(8): 1087–92.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lorber, M. (2008). Henoch-Shoenlein Purpura. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_26
Download citation
DOI: https://doi.org/10.1007/978-1-60327-285-8_26
Publisher Name: Humana Press
Print ISBN: 978-1-60327-427-2
Online ISBN: 978-1-60327-285-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)